Shares of Arena Pharmaceuticals (ARNA -1.4%) are halted pending news that U.S. regulators have...

|About: Arena Pharmaceuticals, Inc. (ARNA)|By:, SA News Editor

Shares of Arena Pharmaceuticals (ARNA -1.4%) are halted pending news that U.S. regulators have approved its weight-loss drug Belviq - formerly known as lorcaserin. The announcement is expected but notable nonetheless, due to the fact that it will be the first new prescription diet pill to be cleared for sale in the U.S. in over 13 years.